Zobrazeno 1 - 6
of 6
pro vyhledávání: '"İlker Nihat Ökten"'
Autor:
Çiğdem Yıldırım, Fatih Teker, İlker Nihat Ökten, İlkay Gültürk, Aydın Aytekin, Alper Aytekin, Latif Yılmaz, Çiğdem Usul Afşar
Publikováno v:
İstanbul Medical Journal, Vol 25, Iss 4, Pp 274-280 (2024)
Introduction: Breast cancer is the most common malignancy in women, and it is the second leading cause of malignancy-related mortality in women after lung cancer. Locally advanced breast cancer is a clinically heterogeneous group with a broad spectru
Externí odkaz:
https://doaj.org/article/e32a2ade1a874c5a91a60a3e9550ebf9
Autor:
Ozkan Alan, Tugba Akin Telli, Bilge Aktas, Sinan Koca, Ilker Nihat Ökten, Rahib Hasanov, Tugba Basoglu, Rukiye Arikan, Nazim Can Demircan, Ozlem Ercelep, Serap Kaya, Mustafa Umit Ugurlu, Handan Kaya, Nalan Akgul Babacan, Faysal Dane, Perran Fulden Yumuk
Publikováno v:
World Journal of Surgical Oncology, Vol 18, Iss 1, Pp 1-9 (2020)
Abstract Purpose Neoadjuvant chemotherapy is the standard front-line treatment modality in locally advanced breast cancer. Achieving pathological complete response (pCR) is a significant prognostic factor for prolonged disease-free and overall surviv
Externí odkaz:
https://doaj.org/article/9854984b8d9e4981ac56e556ec7b4c9c
Autor:
İbrahim ÇİL, Abdilkerim OYMAN, Selver IŞIK, Murat AYHAN, İlker Nihat ÖKTEN, Mesut YILMAZ, Melike ÖZÇELİK
Publikováno v:
Journal of Oncological Sciences. 7:125-132
Autor:
Sinan Koca, Esra Koca, ilker nihat Ökten, Fatma feriha Orengul, akın Ozturk, melike özçelik, Abdilkerim Oyman, Mahmut Gumus
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
Volume: 11, Issue: 3 386-390
Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
Aim: Blood group antigens are the first genetic markers discovered. ABO blood groups which are expressed on red blood cell membranes are reported to be associated with malignancy risk. The present study aimed to investigate whether there is an associ
Publikováno v:
JCO Global Oncology, Iss 10 (2024)
PURPOSESyrian refugees (SRs) have had difficulties in the diagnosis, treatment, and follow-up of chronic diseases, such as cancer, because of the conflict in the region. The cancer diagnosis and treatment process of SR are also a matter of curiosity.
Externí odkaz:
https://doaj.org/article/280578b6c5a34e74a674ae357502f92f